Status:
RECRUITING
Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
Lead Sponsor:
Tanta University
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE3
Brief Summary
Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children
Detailed Description
Study of Novel triple Nitazoxanide (NTZ) based new therapeutic regimens for Helicobacter pylori in children
Eligibility Criteria
Inclusion
- \- Positive helicobacter infection.
Exclusion
- Previous treatment for H. Pylori.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04415983
Start Date
June 1 2020
End Date
December 1 2030
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sherief Abd-Elsalam
Tanta, Egypt